Occupational exposures and exacerbations of asthma and COPD—A general population study
暂无分享,去创建一个
B. Nordestgaard | C. Brauer | J. Bonde | S. Sadhra | E. Flachs | V. Schlünssen | P. Lange | O. Kurmi | J. Marott | S. Skaaby
[1] E. Budtz-Jørgensen,et al. Cohort Profile: DOC*X: a nationwide Danish occupational cohort with eXposure data - an open research resource. , 2019, International journal of epidemiology.
[2] B. Nordestgaard,et al. Prognosis of COPD depends on severity of exacerbation history: A population-based analysis. , 2019, Respiratory medicine.
[3] H. Kan,et al. Associations between short-term exposure to fine particulate matter and acute exacerbation of asthma in Yancheng, China. , 2019, Chemosphere.
[4] N. Seersholm,et al. COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months , 2019, BMJ Open Respiratory Research.
[5] Asthma diagnosed in late adulthood is linked to work disability and poor employment status. , 2019, Respiratory medicine.
[6] A. Burdorf,et al. A nationwide follow-up study of occupational organic dust exposure and risk of chronic obstructive pulmonary disease (COPD) , 2018, Occupational and Environmental Medicine.
[7] M. Strand,et al. Health Services Utilization in Asthma Exacerbations and PM10 Levels in Rural Colorado , 2018, Annals of the American Thoracic Society.
[8] P. Jousilahti,et al. 30-year trends in asthma and the trends in relation to hospitalization and mortality. , 2018, Respiratory medicine.
[9] H. Kromhout,et al. Update of an occupational asthma-specific job exposure matrix to assess exposure to 30 specific agents , 2018, Occupational and Environmental Medicine.
[10] M. Kogevinas,et al. Occupational exposures and 20-year incidence of COPD: the European Community Respiratory Health Survey , 2018, Thorax.
[11] P. Busse,et al. Asthma in the elderly and late‐onset adult asthma , 2018, Allergy.
[12] L. Smeeth,et al. Exacerbation risk and characterisation of the UK’s asthma population from infants to old age , 2017, Thorax.
[13] T. H. Nguyen,et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet. Respiratory medicine.
[14] W. Busse,et al. Asthma Exacerbations: Pathogenesis, Prevention, and Treatment , 2017, The Journal of Allergy and Clinical Immunology: In Practice.
[15] R. Suruki,et al. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA , 2017, BMC Pulmonary Medicine.
[16] D. Fitzmaurice,et al. Birmingham COPD Cohort: a cross-sectional analysis of the factors associated with the likelihood of being in paid employment among people with COPD , 2017, International journal of chronic obstructive pulmonary disease.
[17] R. Tang,et al. Major air pollutants and risk of COPD exacerbations: a systematic review and meta-analysis , 2016, International journal of chronic obstructive pulmonary disease.
[18] K. Torén,et al. Impact of occupational exposures on exacerbation of asthma: a population-based asthma cohort study , 2016, BMC Pulmonary Medicine.
[19] S. Sadhra,et al. Development of an occupational airborne chemical exposure matrix. , 2016, Occupational medicine.
[20] J. Vestbo,et al. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. , 2016, The Lancet. Respiratory medicine.
[21] J. Goddard,et al. Acute exacerbation of COPD , 2016, Respirology.
[22] J. Hallas,et al. Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition. , 2015, Respiratory medicine.
[23] Aziz Sheikh,et al. Global and regional estimates of COPD prevalence: Systematic review and meta–analysis , 2015, Journal of global health.
[24] Dirkje S Postma,et al. The Asthma-COPD Overlap Syndrome. , 2015, The New England journal of medicine.
[25] G. Diette,et al. Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease. , 2015, American journal of respiratory and critical care medicine.
[26] Børge G. Nordestgaard,et al. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome. , 2014, JAMA internal medicine.
[27] Su-Jau Yang,et al. Overweight/obesity and risk of seasonal asthma exacerbations. , 2013, The journal of allergy and clinical immunology. In practice.
[28] T. Sigsgaard,et al. Consequences of asthma on job absenteeism and job retention , 2012, Scandinavian journal of public health.
[29] H. Boushey,et al. Asthma outcomes: exacerbations. , 2012, The Journal of allergy and clinical immunology.
[30] Elsebeth Lynge,et al. The Danish National Patient Register , 2011, Scandinavian journal of public health.
[31] J. Hallas,et al. The Danish National Prescription Registry , 2011, Scandinavian journal of public health.
[32] L. Tzivian. Outdoor Air Pollution and Asthma in Children , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.
[33] D. Jarvis,et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. , 2011, American journal of respiratory and critical care medicine.
[34] D. Mannino,et al. COPD in Never Smokers , 2011, Chest.
[35] M. Kogevinas,et al. The occupational contribution to severe exacerbation of asthma , 2010, European Respiratory Journal.
[36] S. Antoniu. UPLIFT Study: the effects of long-term therapy with inhaled tiotropium in chronic obstructive pulmonary disease , 2009, Expert opinion on pharmacotherapy.
[37] S. Willsie. Severe exacerbations predict excess lung function decline in asthma , 2009 .
[38] E. Bleecker,et al. Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility. , 2008, Pulmonary pharmacology & therapeutics.
[39] Hans Kromhout,et al. Trends in inhalation exposure--a review of the data in the published scientific literature. , 2007, The Annals of occupational hygiene.
[40] T. Seemungal,et al. COPD exacerbations: defining their cause and prevention , 2007, The Lancet.
[41] Sally E Wenzel,et al. Recent asthma exacerbations: a key predictor of future exacerbations. , 2007, Respiratory medicine.
[42] W. Vollmer,et al. Predictors of Asthma Control in a Random Sample of Asthmatic Patients , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.
[43] L Alfredsson,et al. Incidence of asthma among workers exposed to sulphur dioxide and other irritant gases , 2006, European Respiratory Journal.
[44] R. Stockley,et al. COPD exacerbations · 2: Aetiology , 2006, Thorax.
[45] M. Martínez-García,et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease , 2005, Thorax.
[46] T. Gislason,et al. A prospective study of asthma incidence and its predictors: the RHINE study , 2004, European Respiratory Journal.
[47] J. Banegas,et al. Short-term effects of air pollution on daily asthma emergency room admissions , 2003, European Respiratory Journal.
[48] Kathleen Kreiss,et al. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. , 2003, American journal of respiratory and critical care medicine.
[49] B. Nordestgaard,et al. The Copenhagen City Heart Study , 2003 .
[50] T. Truelsen,et al. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. , 2001, International journal of epidemiology.
[51] B G Armstrong,et al. Effect of measurement error on epidemiological studies of environmental and occupational exposures. , 1998, Occupational and environmental medicine.
[52] 北村 聖. "The New England Journal of Medicine". , 1962, British medical journal.